GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (OTCPK:SEMHF) » Definitions » 3-Year EBITDA Growth Rate
中文

Siemens Healthineers AG (Siemens Healthineers AG) 3-Year EBITDA Growth Rate : 5.90% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG 3-Year EBITDA Growth Rate?

Siemens Healthineers AG's EBITDA per Share for the three months ended in Dec. 2023 was $0.91.

During the past 12 months, Siemens Healthineers AG's average EBITDA Per Share Growth Rate was -6.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 5.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Siemens Healthineers AG was 8.80% per year. The lowest was -0.30% per year. And the median was 4.20% per year.

Competitive Comparison of Siemens Healthineers AG's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Siemens Healthineers AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Siemens Healthineers AG's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's 3-Year EBITDA Growth Rate falls into.


Siemens Healthineers AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Siemens Healthineers AG  (OTCPK:SEMHF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Siemens Healthineers AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Siemens Healthineers AG (Siemens Healthineers AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (OTCPK:SEMHF) » Definitions » 3-Year EBITDA Growth Rate
Comparable Companies
LSE:SN. LSE:NIOX LSE:MXCT LSE:EKF LSE:CREO LSE:BELL LSE:IUG LSE:IHC LSE:POLX LSE:SUN ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
SMMNY:USA 1SHL:Italy SHLd:UK SHL1:Germany SHL:Germany SHL:Germany SHL:Germany SHL:Germany SHL:Austria
Address
Siemensstr. 3, Forchheim, BY, DEU, 91301
Website
https://www.siemens-healthineers.com
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.